The effects of alcohol use on smoking cessation treatment with nicotine replacement therapy: An observational study.

What Was Tested

This observational study looks at Therapeutic nicotine (patch, non-peptide).

Concurrent users of tobacco and alcohol are at greater risk of harm than use of either substance alone.

It remains unclear how concurrent tobacco and alcohol use affects smoking cessation across levels of alcohol use and related problems.

Who Took Part

According to the abstract, 59,018 participants were involved.

By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.

59,018 participants received nicotine replacement therapy through a smoking cessation program.

How the Study Was Run

Alcohol use and related symptoms were assessed using the Alcohol Use Disorders Identification Test (AUDIT-10) and the AUDIT-Concise (AUDIT-C).

The primary outcome was 7-day point prevalence cigarette abstinence (PPA) at 6-month follow-up.

The researchers evaluated the association between alcohol use (and related problems) and smoking cessation using descriptive methods and mixed-effects logistic regression.

What Was Measured

It remains unclear how concurrent tobacco and alcohol use affects smoking cessation across levels of alcohol use and related problems.

This study assessed the relationship between smoking cessation and levels of alcohol use problems.

Topics PubMed links to this paper include Smoking Cessation, Tobacco Use Cessation Devices, Alcohol Drinking, Alcoholism, Tobacco Use Disorder and Nicotine Replacement Therapy.

What This Means in Plain Language

This is an observational study of Therapeutic nicotine (patch, non-peptide) in 59,018 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2024 (Addictive behaviors), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.